Overview

Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to: 1. Study the pharmacokinetics and safety of daptomycin in children on hemodialysis (HD) and peritoneal dialysis (PD). 2. Determine urine, HD and PD clearance of daptomycin.
Phase:
N/A
Details
Lead Sponsor:
University of Oklahoma
Collaborator:
Cubist Pharmaceuticals LLC
Treatments:
Daptomycin